Cases 11 - 20 of 147
Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc.
as 23-2254
Plaintiff / Appellee:
MERCK SHARP & DOHME B.V. and MERCK SHARP & DOHME, LLC
Defendant / Appellant:
AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA LTD., USV PRIVATE LIMITED and others
Defendant:
LUPIN LTD., LUPIN PHARMACEUTICALS, INC. and LUPIN INC.
Galderma Laboratories, L.P. et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2023cv00711
Plaintiff:
Galderma Laboratories, L.P. and TCD Royalty Sub LP
Defendant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAUSCH & LOMB INCORPORATED et al v. DR. REDDY'S LABORATORIES LTD. et al
as 3:2023cv03463
Plaintiff:
BAUSCH & LOMB INCORPORATED, BAUSCH & LOMB IRELAND LIMITED and NICOX S.A.
Defendant:
DR. REDDY'S LABORATORIES LTD. and DR. REDDY'S LABORATORIES INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Horizon Therapeutics USA Inc. et al v. Dr. Reddys Laboratories, Ltd. et al
as 1:2023cv00623
Plaintiff:
Horizon Therapeutics USA Inc. and Horizon Therapeutics Ireland DAC
Defendant:
Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.
Counter Claimant:
Dr. Reddy's Laboratories, Ltd. and Dr. Reddy's Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAUSCH & LOMB, INC. et al v. SLAYBACK PHARMA LLC et al
as 3:2023cv02454
Counter Defendant:
BAUSCH & LOMB, INC.
Plaintiff:
BAUSCH & LOMB IRELAND LIMITED and EYE THERAPIES, LLC
Defendant:
SLAYBACK PHARMA LLC, SLAYBACK PHARMA INDIA LLP, DR. REDDYS LABORATORIES S.A. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG et al v. Dr. Reddy's Laboratories, Ltd. et al
as 1:2023cv00410
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
Dr. Reddys Laboratories, Ltd., Dr. Reddys Laboratories, Inc., Dr. Reddy's Laboratories Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eli Lilly and Company v. Dr. Reddys Laboratories, Ltd. et al
as 1:2022cv01355
Plaintiff:
Eli Lilly and Company
Defendant:
Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
EISAI R&D MANAGEMENT CO., LTD. et al v. DR. REDDYS LABORATORIES, INC. et al
as 3:2022cv05950
Plaintiff:
EISAI R&D MANAGEMENT CO., LTD., EISAI CO., LTD. and EISAI INC.
Defendant:
DR. REDDYS LABORATORIES, INC. and DR. REDDYS LABORATORIES, LTD.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Dr. Reddy's Laboratories Ltd. et al
as 1:2022cv01102
Plaintiff:
Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH and Boehringer Ingelheim Corporation
Defendant:
Dr. Reddys Laboratories Ltd., Dr. Reddys Laboratories, Inc., Dr. Reddy's Laboratories Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
